Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 3.39%1.96B | 2.71%7.55B | 3.75%1.82B | 3.48%1.91B | 1.76%1.92B | 1.94%1.9B | 5.24%7.35B | 3.72%1.76B | 2.41%1.85B | 5.88%1.88B |
Operating revenue | 3.39%1.96B | 2.71%7.55B | 3.75%1.82B | 3.48%1.91B | 1.76%1.92B | 1.94%1.9B | 5.24%7.35B | 3.72%1.76B | 2.41%1.85B | 5.88%1.88B |
Cost of revenue | 4.06%1.08B | 3.80%4.14B | 4.91%1.01B | 5.34%1.05B | 2.64%1.05B | 2.42%1.03B | 6.04%3.99B | 3.45%959.2M | 2.30%998.3M | 7.84%1.03B |
Gross profit | 2.59%883.9M | 1.41%3.4B | 2.35%818.2M | 1.30%858.6M | 0.70%863.5M | 1.36%861.6M | 4.31%3.35B | 4.03%799.4M | 2.55%847.6M | 3.61%857.5M |
Operating expense | 3.95%490M | 3.62%1.89B | 6.24%473.4M | 2.08%470.5M | 3.03%476.6M | 3.20%471.4M | 3.61%1.83B | 2.32%445.6M | 3.04%460.9M | 4.14%462.6M |
Selling and administrative expenses | 3.95%490M | 3.62%1.89B | 6.24%473.4M | 2.08%470.5M | 3.03%476.6M | 3.20%471.4M | 3.61%1.83B | 2.32%445.6M | 3.04%460.9M | 4.14%462.6M |
Operating profit | 0.95%393.9M | -1.22%1.51B | -2.54%344.8M | 0.36%388.1M | -2.03%386.9M | -0.76%390.2M | 5.17%1.53B | 6.28%353.8M | 1.98%386.7M | 3.00%394.9M |
Net non-operating interest income expense | -100.00%-800K | 71.64%-1.9M | -225.00%-500K | 61.54%-500K | 78.26%-500K | 88.57%-400K | 50.74%-6.7M | 108.51%400K | 66.67%-1.3M | 14.81%-2.3M |
Non-operating interest income | -43.75%900K | 31.71%5.4M | -47.83%1.2M | 62.50%1.3M | 116.67%1.3M | 300.00%1.6M | 485.71%4.1M | 666.67%2.3M | 300.00%800K | 500.00%600K |
Non-operating interest expense | -15.00%1.7M | -32.41%7.3M | -10.53%1.7M | -14.29%1.8M | -37.93%1.8M | -48.72%2M | -24.48%10.8M | -62.00%1.9M | -48.78%2.1M | 3.57%2.9M |
Other net income (expense) | ||||||||||
Income before tax | 0.85%393.1M | -0.91%1.51B | -2.80%344.3M | 0.57%387.6M | -1.58%386.4M | 0.03%389.8M | 5.69%1.52B | 7.92%354.2M | 2.69%385.4M | 3.13%392.6M |
Income tax | 2.50%94.4M | -2.59%357.5M | -6.38%82.2M | -0.44%89.5M | -0.95%93.7M | -2.64%92.1M | 3.94%367M | 6.30%87.8M | -0.88%89.9M | 1.07%94.6M |
Net income | 0.34%298.7M | -0.38%1.15B | -1.61%262.1M | 0.88%298.1M | -1.78%292.7M | 0.88%297.7M | 6.27%1.16B | 8.47%266.4M | 3.83%295.5M | 3.80%298M |
Net income continuous Operations | 0.34%298.7M | -0.38%1.15B | -1.61%262.1M | 0.88%298.1M | -1.78%292.7M | 0.88%297.7M | 6.27%1.16B | 8.47%266.4M | 3.83%295.5M | 3.80%298M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 0.34%298.7M | -0.38%1.15B | -1.61%262.1M | 0.88%298.1M | -1.78%292.7M | 0.88%297.7M | 6.27%1.16B | 8.47%266.4M | 3.83%295.5M | 3.80%298M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 0.34%298.7M | -0.38%1.15B | -1.61%262.1M | 0.88%298.1M | -1.78%292.7M | 0.88%297.7M | 6.27%1.16B | 8.47%266.4M | 3.83%295.5M | 3.80%298M |
Basic earnings per share | 0.00%0.52 | -0.50%2.01 | -2.13%0.46 | 0.00%0.52 | -1.92%0.51 | 0.00%0.52 | 6.88%2.02 | 9.30%0.47 | 4.00%0.52 | 4.00%0.52 |
Diluted earnings per share | 0.00%0.52 | -0.99%2 | 0.00%0.46 | 0.00%0.52 | -1.92%0.51 | 0.00%0.52 | 6.88%2.02 | 6.98%0.46 | 4.00%0.52 | 4.00%0.52 |
Dividend per share | 10.26%0.43 | 11.43%1.56 | 11.43%0.39 | 11.43%0.39 | 11.43%0.39 | 11.43%0.39 | 12.90%1.4 | 12.90%0.35 | 12.90%0.35 | 12.90%0.35 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |